Raia Drogasil S.A. (BVMF:RADL3)

Market Cap	32.40B -5.1%
Revenue (ttm)	45.55B +16.7%
Net Income	1.29B +9.9%
EPS	0.78 +11.5%
Shares Out	1.75B
PE Ratio	23.61
Forward PE	18.78
Dividend	0.40 (2.16%)
Ex-Dividend Date	Apr 7, 2026

Volume	14,480,400
Average Volume	10,137,380
Open	18.71
Previous Close	19.12
Day's Range	18.47 - 19.11
52-Week Range	12.81 - 27.42
Beta	0.11
RSI	24.17
Earnings Date	May 5, 2026

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1905
• Employees: 75,190
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: RADL3

Financial Performance

In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.